idebenone has been researched along with MS (Multiple Sclerosis) in 3 studies
Excerpt | Relevance | Reference |
---|---|---|
"Idebenone was well tolerated but did not inhibit disability progression or CNS tissue destruction." | 2.94 | Idebenone does not inhibit disability progression in primary progressive MS. ( Bielekova, B; Komori, M; Kosa, P; Leinonen, M; Masvekar, R; Phillips, J; Sandford, M; Wichman, A; Wu, T, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Kosa, P | 1 |
Wu, T | 1 |
Phillips, J | 1 |
Leinonen, M | 1 |
Masvekar, R | 1 |
Komori, M | 1 |
Wichman, A | 1 |
Sandford, M | 1 |
Bielekova, B | 1 |
Chang, M | 1 |
Szewka, AJ | 1 |
Toffoli, D | 1 |
Newman, NJ | 1 |
Biousse, V | 1 |
1 trial available for idebenone and MS (Multiple Sclerosis)
Article | Year |
---|---|
Idebenone does not inhibit disability progression in primary progressive MS.
Topics: Axons; Biomarkers; Disease Progression; Double-Blind Method; Humans; Multiple Sclerosis; Multiple Sc | 2020 |
2 other studies available for idebenone and MS (Multiple Sclerosis)
Article | Year |
---|---|
Leber's hereditary optic neuropathy misdiagnosed as optic neuritis and Lyme disease in a patient with multiple sclerosis.
Topics: Adult; Antioxidants; Diagnosis, Differential; Diagnostic Errors; Humans; Lyme Disease; Magnetic Reso | 2018 |
Updates in neuro-ophthalmology. Highlights from the 37th annual meeting of the North American Neuro-Ophthalmology Society,February 5-10, 2011, Vancouver, Canada.
Topics: Burkholderia; Canada; Giant Cell Arteritis; Humans; Multiple Sclerosis; Neurology; Ophthalmology; Op | 2011 |